Kimialys is an innovative industrial biosensing company on a mission to set new standards in biomolecule detection and characterization. Leveraging its proprietary K-One surface chemistry, Kimialys enables R&D teams worldwide to tackle ambitious projects and develop tomorrow’s therapeutics and diagnostics, by making standard in vitro analysis tools suitable for the most innovative biologics and biomarkers.
Over the past five years, we’ve been working with partners across industry and academia, demonstrating and strengthening the impact of our technology for cutting-edge in vitro analyses and high-throughput experiments. With over 100 projects delivered on complex real-world applications, we are contributing to the most innovative assays under development.
We are proud to gather a team with unique transversal skills, at the crossroads of chemistry, physics, and biology and to be supported by seasoned investors and board members. Together, we are writing our industrial journey to successfully turn our patented technology into a global-impact innovation.

120+
Projects worldwide
$4.5M
Raised in private financing
11 PhDs
Experts in chemistry applied to biosensing
80%
Global customers
They support us







